Reuters Market Eye - Nomura Equity Research is "overweight" on rate cyclicals and defensive growth plays but remains "underweight" on domestic growth cyclicals.
The investment banking company says following the contraction in global risk premiums in the second half of 2012 and the simultaneous rally in risky assets, it expects the focus to turn to domestic fundamentals this year.
India's growth will be slow to revive, but easing pressure on current account deficit and inflation suggest a benign rate and liquidity environment.
Nomura expects to see the benchmark Sensex at 21,700 at end-March.
ICICI Bank Ltd , ITC Ltd , Mahindra & Mahindra Ltd , Dr Reddy Laboratories Ltd and Zee Entertainment Ltd are top bets for the year.
(Reporting by Archana Narayanan)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app